XML 39 R25.htm IDEA: XBRL DOCUMENT
v3.25.0.1

Net Loss Per Share | 12 Months Ended
--- | ---
Dec. 31, 2024
Net Loss Per Share |
Net Loss Per Share | 17. Net Loss per Share The denominators used in the net loss per share computations are as follows:
​ | ​ | ​ | ​ | ​ | ​ | ​
​ | ​ | ​
​ | ​ | Year Ended December 31,
​ |  | 2024 |  | 2023 |  | 2022
Basic: |  |  |  |  |  |
Weighted average common shares outstanding |  | 4,562,738 |  | 4,512,422 |  | 4,471,130
Diluted: |  |  |  |  |  |
Weighted average common shares outstanding - Basic |  | 4,562,738 |  | 4,512,422 |  | 4,471,130
Common stock equivalents* |  | — |  | — |  | —
Denominator for diluted net loss per share |  | 4,562,738 |  | 4,512,422 |  | 4,471,130
* | For the years ended December 31, 2024, 2023 and 2022, no amounts were considered common stock equivalents as their effects would have been anti-dilutive due to net losses for those periods.
Basic and diluted net loss per share is computed as follows:
​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
​ | ​ | ​
​ | ​ | Year Ended December 31,
​ |  | 2024 |  | 2023 |  | 2022
Net loss - basic and diluted | ​ | $ | (70,867) | ​ | $ | (118,513) | ​ | $ | (85,474)
Weighted-average common shares outstanding: | ​ |  | ​ | ​ |  | ​ | ​ |  | ​
Basic and diluted | ​ |  | 4,562,738 | ​ |  | 4,512,422 | ​ |  | 4,471,130
Net loss per share, basic and diluted: | ​ | $ | (15.53) | ​ | $ | (26.26) | ​ | $ | (19.12)
​ As of December 31, 2024, 340,460 stock options and 79,913 restricted stock units were outstanding, which could potentially dilute basic earnings per share in the future, but were not included in the computation of diluted net loss per share because to do so would have been anti-dilutive as a result of the net loss for the period. As of December 31, 2023, 658,138 stock options and 47,194 restricted stock units were outstanding, which could potentially dilute basic earnings per share in the future, but were not included in the computation of diluted net loss per share because to do so would have been anti-dilutive as a result of the net loss for the period. As of December 31, 2022, 640,787 stock options and 31,043 restricted stock units were outstanding, which could potentially dilute basic earnings per share in the future, but were not included in the computation of diluted net loss per share because to do so would have been anti-dilutive as a result of the net loss for the period.

X
- References No definition available. + Details
Name: | us-gaap_EarningsPerShareAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure for earnings per share. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 260 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 1 -Subparagraph (c) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Topic 260 -Name Accounting Standards Codification -Publisher FASB -URI https://asc.fasb.org/260/tableOfContent Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Topic 260 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482662/260-10-50-2 Reference 4: http://www.xbrl.org/2003/role/disclosureRef -Topic 260 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 3 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482662/260-10-50-3 + Details
Name: | us-gaap_EarningsPerShareTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration